These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28683085)

  • 21. Identification of a thrombin-interactive site within the FVIII A2 domain that is responsible for the cleavage at Arg372.
    Nogami K; Saenko EL; Takeyama M; Giddings JC; Yoshioka A; Shima M
    Br J Haematol; 2008 Feb; 140(4):433-43. PubMed ID: 18081893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of factor VIII 372-Cys: a hypofunctional cofactor from a patient with moderately severe hemophilia A.
    O'Brien DP; Pattinson JK; Tuddenham EG
    Blood; 1990 Apr; 75(8):1664-72. PubMed ID: 2109644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa.
    Pipe SW; Kaufman RJ
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11851-6. PubMed ID: 9342326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency.
    Plantier JL; Rolli V; Ducasse C; Dargaud Y; Enjolras N; Boukerche H; Négrier C
    J Thromb Haemost; 2010 Feb; 8(2):286-93. PubMed ID: 19874476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
    Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
    Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-terminal acidic region in the A1 domain of factor VIII facilitates thrombin-catalyzed activation and cleavage at Arg
    Nakajima Y; Nogami K
    J Thromb Haemost; 2021 Mar; 19(3):677-688. PubMed ID: 33369157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cathepsin G, a leukocyte protease, activates coagulation factor VIII.
    Gale AJ; Rozenshteyn D
    Thromb Haemost; 2008 Jan; 99(1):44-51. PubMed ID: 18217133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural studies on the decameric S. typhimurium arginine decarboxylase (ADC): Pyridoxal 5'-phosphate binding induces conformational changes.
    Deka G; Bharath SR; Savithri HS; Murthy MRN
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1362-1368. PubMed ID: 28694189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residues surrounding Arg336 and Arg562 contribute to the disparate rates of proteolysis of factor VIIIa catalyzed by activated protein C.
    Varfaj F; Wakabayashi H; Fay PJ
    J Biol Chem; 2007 Jul; 282(28):20264-72. PubMed ID: 17519239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteamine enhances the procoagulant activity of Factor VIII-East Hartford, a dysfunctional protein due to a light chain thrombin cleavage site mutation (arginine-1689 to cysteine).
    Aly AM; Arai M; Hoyer LW
    J Clin Invest; 1992 May; 89(5):1375-81. PubMed ID: 1569180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal factor VIII Hiroshima: defect in crucial proteolytic cleavage by thrombin at Arg1689 detected by a novel ELISA.
    Kamisue S; Shima M; Nishimura T; Tanaka I; Nakai H; Morichika S; Takata N; Kuramoto A; Yoshioka A
    Br J Haematol; 1994 Jan; 86(1):106-11. PubMed ID: 8011517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cofactor activity in factor VIIIa of the blood clotting pathway is stabilized by an interdomain bond between His281 and Ser524 formed in factor VIII.
    Wakabayashi H; Monaghan M; Fay PJ
    J Biol Chem; 2014 May; 289(20):14020-9. PubMed ID: 24692542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure/cleavage-based insights into helical perturbations at bulge sites within T. thermophilus Argonaute silencing complexes.
    Sheng G; Gogakos T; Wang J; Zhao H; Serganov A; Juranek S; Tuschl T; Patel DJ; Wang Y
    Nucleic Acids Res; 2017 Sep; 45(15):9149-9163. PubMed ID: 28911094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining mutations that modulate inter-subunit interactions and proteolytic inactivation enhance the stability of factor VIIIa.
    Wakabayashi H; Wintermute JM; Fay PJ
    Thromb Haemost; 2014 Jul; 112(1):43-52. PubMed ID: 24599523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Importance of Exosite Interactions for Substrate Cleavage by Human Thrombin.
    Chahal G; Thorpe M; Hellman L
    PLoS One; 2015; 10(6):e0129511. PubMed ID: 26110612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
    Yada K; Nogami K; Ogiwara K; Shibata M; Shima M
    Thromb Haemost; 2011 Jun; 105(6):989-98. PubMed ID: 21437361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation.
    Suzuki H; Shima M; Nogami K; Sakurai Y; Nishiya K; Saenko EL; Tanaka I; Yoshioka A
    J Thromb Haemost; 2006 Jun; 4(6):1354-60. PubMed ID: 16706982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin.
    Iqbal A; Goldfeder MB; Marques-Porto R; Asif H; Souza JG; Faria F; Chudzinski-Tavassi AM
    Sci Rep; 2017 May; 7(1):1431. PubMed ID: 28469161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.